《新股消息》华住集团(01179.HK)公开发售超购逾2倍 一手中签率100%
华住集团(01179.HK)公布招股结果,以297元定价,香港公开发售部分超额认购2.39倍,国际发售超额认购5.6倍;每手50股,中签率100%。该股将於明日(22日)上市。高盛、招银国际为联席保荐人。
公司预计集资净额59.25亿元,当中约40%将用於支持集团资本支出及开支,以加强酒店网络包括新酒店开业以及现有酒店的升级及持续维护;约30%将用於偿还循环信贷融资的一部分;约20%将用於增强集团技术平台;约10%将用於一般公司用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.